一位68歲女性因急性深部靜脈栓塞（DVT）住院，目前正同時接受連續靜脈注射肝素 (Heparin) 以及口服華法林 (Warfarin/Coumadin) 的重疊『橋接』治療。早晨的血液實驗室報告送達。護理師注意到個案的 aPTT 嚴重飆升至 120 秒（正常對照值：30秒），且 PT/INR 也出現 5.5 的驚人巨大峰值。個案突然開始流出大量、無法控制的嚴重鼻血並出現血尿。為了緊急對抗並將病患從這場災難性的出血大屠殺中拯救出來，護理師應預期針對這兩種藥物分別給予哪種特定的生理學解毒劑？
A 68-year-old female is hospitalized for an acute deep vein thrombosis (DVT) and is currently undergoing overlapping "bridge" therapy with both a continuous intravenous Heparin infusion and oral Warfarin (Coumadin). Morning laboratory results arrive. The nurse notes the client's aPTT is profoundly elevated at 120 seconds (Control: 30 seconds) and the PT/INR demonstrates a massive spike at 5.5. The client abruptly begins enduring severe, uncontrollable epistaxis (nosebleeds) and hematuria. To urgently counteract and rescue the client from these catastrophic hemorrhages, which specific physiological antidotes must the nurse anticipate administering for each respective medication?
- AAdminister Vitamin K to reverse the Heparin toxicity; administer Protamine sulfate to reverse the Warfarin toxicity.給予維生素K以逆轉肝素毒性；給予魚精蛋白以逆轉華法林毒性
- BAdminister Protamine sulfate to reverse the Heparin toxicity; administer Vitamin K to reverse the Warfarin toxicity.✓ 正解給予魚精蛋白以逆轉肝素毒性；給予維生素K以逆轉華法林毒性
- CAdminister fresh frozen plasma (FFP) to reverse the Heparin toxicity; administer Acetylcysteine to reverse the Warfarin toxicity.給予新鮮冷凍血漿以逆轉肝素毒性；給予乙醯半胱胺酸以逆轉華法林毒性
- DAdminister Naloxone to reverse the Heparin toxicity; administer Flumazenil to reverse the Warfarin toxicity.給予納洛酮以逆轉肝素毒性；給予氟馬西尼以逆轉華法林毒性
本題測驗最常考的抗凝血劑藥理配對：實驗室追蹤與專屬解毒劑（Antidotes）。『肝素（Heparin）』在靜脈注射時作用極快，主要透過緊盯「aPTT」來監測，治療目標大約定在基準值的 1.5 到 2 倍。一旦 aPTT 狂飆（如本例 120），代表血液已薄如水，有隨時腦出血的危險；肝素的專屬解毒劑是「魚精蛋白硫酸鹽（Protamine Sulfate）」。『華法林（Warfarin）』是口服抑制維生素 K 生成的抗凝劑，生效慢，需盯緊「PT/INR」，標準治療目標為 2.0-3.0，一旦長到 5.5 也代表致命大出血邊緣；華法林的專屬解毒劑是其直接的敵人：「維生素 K（Vitamin K 又叫 Phytonadione）」。由於患者正處雙藥物橋接期（Bridge therapy）且全面嚴重超標並伴隨實體出血，必須精準配對兩種解毒劑（選項B為唯一正解）。選項A完全反轉了兩者的配對關係。選項D的解毒劑是分別給鴉片類鎮痛與安眠藥使用的。選項C的 Acetylcysteine 是針對普拿疼（Acetaminophen/Tylenol）肝毒性過量的解毒劑。
This item tests the most commonly tested anticoagulant pharmacology pairing: laboratory monitoring and specific antidotes. Heparin, given intravenously, acts very quickly and is primarily monitored using aPTT, with the therapeutic target set at approximately 1.5 to 2 times the baseline value. Once aPTT becomes severely elevated (as in this case at 120), the blood is essentially as thin as water and the client is at imminent risk of intracerebral hemorrhage; the specific antidote for heparin is Protamine sulfate. Warfarin is an oral anticoagulant that inhibits vitamin K-dependent clotting factor synthesis; its onset is slow and it is monitored using PT/INR, with a standard therapeutic target of 2.0-3.0. An INR rising to 5.5 likewise indicates a state on the brink of life-threatening hemorrhage; the specific antidote for warfarin is its direct opposite, Vitamin K (also called Phytonadione). Because this client is in the middle of dual-drug bridge therapy with widespread serious laboratory overshoot and active bleeding, both antidotes must be precisely matched to their respective drugs (option B is the only correct answer). Option A completely reverses the pairings. Option D lists antidotes used for opioid analgesic and benzodiazepine sedative overdoses, respectively. Option C's Acetylcysteine is the antidote for hepatotoxicity due to acetaminophen (Tylenol) overdose.
世界通用藥理鐵律。Heparin 盯 aPTT，解毒劑 Protamine Sulfate; Warfarin 盯 PT/INR，解毒劑 Vitamin K。這配對是全世界護理學生被規定刻在靈魂裡的表格，完全一致。